Genome-wide association studies have discovered that polymorphisms in TGFBR1, a receptor transducing TGFβ signals in conjunction with TGFBR2, influence the risk for developing AMD (Fan et al., 2017; Fritsche et al., 2013). Here, TGFBR2 is linked to age-related macular degeneration.